Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update.
Clarity Pharmaceuticals Ltd. has announced the application for quotation of new securities on the ASX, with a total of 321,146 ordinary fully paid shares to be quoted following their issue on the 16th and 17th of September 2024. This move signifies a potential expansion and increased liquidity for investors, marking an important event for those tracking the company’s financial growth.
For further insights into AU:CU6 stock, check out TipRanks’ Stock Analysis page.
